Insider Selling: Kits Eyecare (TSE:KITS) Insider Sells C$1,023,750.00 in Stock

Posted by on Jun 14th, 2026

Kits Eyecare Ltd (TSE:KITS – Get Free Report) insider Joseph Thompson sold 75,000 shares of the stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of C$13.65, for a total transaction of C$1,023,750.00. Following the completion of the transaction, the insider directly owned 960,114 shares in the company, valued at C$13,105,556.10. The trade was a 7.25% decrease in their ownership of the stock.

Kits Eyecare Price Performance

Shares of KITS opened at C$14.14 on Friday. The company has a market capitalization of C$480.69 million, a price-to-earnings ratio of 141.40 and a beta of 0.11. The company has a 50-day moving average of C$13.53. Kits Eyecare Ltd has a fifty-two week low of C$10.61 and a fifty-two week high of C$22.56.

Kits Eyecare (TSE:KITS – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported C$0.06 earnings per share for the quarter. The company had revenue of C$57.47 million during the quarter.

Analyst Ratings Changes

KITS has been the topic of a number of recent research reports. Stifel Nicolaus lowered their price target on shares of Kits Eyecare from C$24.00 to C$21.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. ATB Cormark Capital Markets lowered their price target on shares of Kits Eyecare from C$20.00 to C$16.75 and set a “speculative buy” rating on the stock in a research report on Thursday, May 7th. Canaccord Genuity Group lowered their price target on shares of Kits Eyecare from C$23.00 to C$22.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Finally, Desjardins lowered their price target on shares of Kits Eyecare from C$25.00 to C$23.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of C$20.69.

Check Out Our Latest Stock Analysis on Kits Eyecare

About Kits Eyecare

(Get Free Report)

KITS (TSX: KITS) is one of the world’s fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.

Featured Articles

Receive News & Ratings for Kits Eyecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kits Eyecare and related companies with MarketBeat.com's FREE daily email newsletter.